Toxic interaction of venlafaxine and isocarboxazide.
D000328:Adult; D017109:Akathisia, Drug-Induced / Q000209:etiology; D000928:Antidepressive Agents / Q000009:adverse effects*; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000139:chemically induced; D003511:Cyclohexanols / Q000009:adverse effects*; D004347:Drug Interactions; D006801:Humans; D007520:Isocarboxazid / Q000009:adverse effects*; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects*; D015878:Mydriasis / Q000139:chemically induced; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D012768:Shivering / Q000187:drug effects; D013546:Sweating / Q000187:drug effects; D000069470:Venlafaxine Hydrochloride
D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D007520:Isocarboxazid; D008996:Monoamine Oxidase Inhibitors; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride